Securities Law

SEC Announces Departure of Dan Berkovitz; Megan Barbero Named General Counsel

December 22, 2022

The Securities and Exchange Commission today announced that General Counsel Dan Berkovitz will depart the agency, effective Jan. 31, 2023. Megan Barbero, currently SEC Principal Deputy General Counsel, will be appointed General Counsel, effective upon Mr… Full report at: Read More

Continue reading

SEC Charges Caroline Ellison and Gary Wang with Defrauding Investors in Crypto Asset Trading Platform FTX

December 22, 2022

The Securities and Exchange Commission today charged Caroline Ellison, the former CEO of Alameda Research, and Zixiao (Gary) Wang, the former Chief Technology Officer of FTX Trading Ltd. (FTX), for their roles in a multiyear scheme to defraud equity… Full report at: Read More

Continue reading

Knox et al.

December 21, 2022

SEC Obtains Final Judgments Against Individual and Entity in Multi-Million Dollar International Fraud Scheme Read the full report at Read More

Continue reading

Thor Technologies, Inc. and David Chin

December 21, 2022

SEC Charges Issuer, CEO, and Former CTO for $2.6 Million Unregistered Crypto Asset Securities Offering Read the full report at Read More

Continue reading

Justin W. Keener d/b/a JMJ Financial

December 21, 2022

SEC Wins $10.2 Million Judgment Against Unregistered Penny Stock Dealer Read the full report at Read More

Continue reading

Sarah ten Siethoff Named Deputy Director of the Division of Investment Management

December 21, 2022

The Securities and Exchange Commission announced today that Sarah ten Siethoff has been named Deputy Director of the Division of Investment Management. In addition to serving as Deputy Director, Ms. ten Siethoff will continue serving as the Associate… Full report at: Read More

Continue reading

Oi2Go Media Technologies, Inc. and Anthony Michael Hernandez

December 20, 2022

SEC Charges Florida Media Company and CEO in Offering Fraud Read the full report at Read More

Continue reading

Nader Pourhassan and Kazem Kazempour

December 20, 2022

SEC Charges Former Biotech CEO with Fraud, Insider Trading; Research Firm CEO Also Charged in Scheme Read the full report at Read More

Continue reading

SEC Charges Former CEO of Biotech Company CytoDyn with Fraud, Insider Trading

December 20, 2022

The Securities and Exchange Commission today charged Nader Pourhassan, the former CEO of CytoDyn Inc., with fraud and insider trading in connection with providing misleading information to shareholders about the progress of a clinical research treatment… Full report at: Read More

Continue reading

Brian Kistler and New Opportunity Business Solutions, Inc. a/k/a NOBS

December 19, 2022

SEC Charges Undisclosed Control Person and His Alter-Ego Entity in Penny Stock Scheme Read the full report at Read More

Continue reading